Hims & Hers (HIMS) Share Price Rises 48% Ahead of Earnings Report

Hims & Hers Health Inc. (NYSE:HIMS) experienced a 48.3% increase in its share price week-on-week as investors anticipate its first-quarter earnings report, scheduled for May 11, 2026. The stock's rise is attributed to optimism surrounding its renewed partnership with Novo Nordisk for the sale of Wegovy and Ozempic on the HIMS platform.

By Angelica Ballesteros Mon, April 20, 2026 at 3:54 AM GMT+3 2 min read · Yahoo Finance · April 20, 2026, 00:54 UTC

Tickers: $HIMS $NVO $PRAX

Topics: earnings report partnership pharmaceuticals stock price movement

Read the full article at Yahoo Finance

More World news

Federal Reserve to Designate October 2027 Meeting as Non-Voting Strategic Session CNBC · November 12, 2026, 17:48 UTC
Sprott Physical Platinum and Palladium Trust Reports Q3 Net Income Decline Seeking Alpha · November 12, 2026, 17:47 UTC
Nvidia CEO Jensen Huang Resigns Amidst Market Volatility and AI Sector Shifts Motley Fool · November 12, 2026, 17:45 UTC
Honda to Transition CR-V Lineup to All-Hybrid Powertrains by 2027 Seeking Alpha · November 12, 2026, 17:43 UTC
Sprott Physical Silver Trust USD Reports Q3 Net Income of $425.83 Million Seeking Alpha · November 12, 2026, 17:44 UTC
Nvidia CEO Jensen Huang Resigns Amid Allegations of Personal Misconduct and China Export Control Concerns The Verge · November 12, 2026, 17:44 UTC
NYSE Sees $500 Billion in Market Cap Transfers from Competitors in 2026 PR Newswire · November 12, 2026, 17:45 UTC
Hyperion DeFi Reports Record Net Income and Positive Operating Cash Flow in Q3 2026 Motley Fool · November 12, 2026, 17:40 UTC
Suburban Propane Reports Fiscal 2026 Results with Increased Adjusted EBITDA and RNG Growth Motley Fool · November 12, 2026, 17:40 UTC
Altimmune Reports Third Quarter 2026 Financial Results Amid Increased R&D Spending Motley Fool · November 12, 2026, 17:40 UTC